Study Protocol: The Evaluation Study for Social Cognition Measures in Japan (ESCoM).

developmental disorders facial expression recognition mental disorders quality of life schizophrenia social cognition social functioning test battery

Journal

Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269

Informations de publication

Date de publication:
16 Jul 2021
Historique:
received: 14 06 2021
revised: 07 07 2021
accepted: 14 07 2021
entrez: 6 8 2021
pubmed: 7 8 2021
medline: 7 8 2021
Statut: epublish

Résumé

In schizophrenia, social cognitive impairment is considered one of the greatest obstacles to social participation. Although numerous measures have been developed to assess social cognition, only a limited number of them have become available in Japan. We are therefore planning this evaluation study for social cognition measures in Japan (ESCoM) to confirm their psychometric characteristics and to promote research focused on social cognition. Participants in the cross-sectional observational study will be 140 patients with schizophrenia recruited from three Japanese facilities and 70 healthy individuals. In our primary analysis, we will calculate several psychometric indicators with a focus on whether they can independently predict social functioning. In secondary analyses, we will assess the reliability and validity of the Japanese translations of each measure and conduct an exploratory investigation of patient background, psychiatric symptoms, defeatist performance belief, and gut microbiota as determinants of social cognition. The protocol for this study is registered in UMIN-CTR, unique ID UMIN000043777.

Identifiants

pubmed: 34357134
pii: jpm11070667
doi: 10.3390/jpm11070667
pmc: PMC8305726
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Japan Agency for Medical Research and Development
ID : JP20dk0307092

Références

Schizophr Res. 2019 Sep 5;:
pubmed: 31495702
Cogn Neuropsychiatry. 2015;20(3):198-221
pubmed: 25675960
Compr Psychiatry. 2016 Feb;65:103-9
pubmed: 26773997
Schizophr Bull. 2016 Mar;42(2):494-504
pubmed: 25943125
Schizophr Res Cogn. 2018 Nov 08;15:21-29
pubmed: 30534527
Acta Neuropsychiatr. 2007 Dec;19(6):362-7
pubmed: 26953002
Schizophr Res. 2018 Nov;201:187-195
pubmed: 29958750
Psychiatry Clin Neurosci. 2006 Jun;60(3):332-9
pubmed: 16732750
Schizophr Bull. 2018 Jun 6;44(4):737-748
pubmed: 28981848
Psychol Bull. 1992 Jul;112(1):155-9
pubmed: 19565683
Neuropsychiatr Dis Treat. 2019 Dec 23;15:3511-3518
pubmed: 31920311
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Schizophr Res. 2010 Sep;122(1-3):164-71
pubmed: 20400268
Psychiatry Res. 2020 Feb 26;286:112891
pubmed: 32145477
Schizophr Res. 2004 Jun 1;68(2-3):283-97
pubmed: 15099610
J Abnorm Psychol. 1993 May;102(2):312-8
pubmed: 8315144
Arch Gen Psychiatry. 2012 Dec;69(12):1216-24
pubmed: 23026889
Schizophr Bull. 2007 Nov;33(6):1364-72
pubmed: 17341468
Schizophr Res. 2019 Feb;204:23-29
pubmed: 30268819
Schizophr Res. 2020 Jan;215:463-464
pubmed: 31615739
Trends Cogn Sci. 2018 Jul;22(7):611-636
pubmed: 29907531
Brain Dev. 2004 Aug;26(5):301-6
pubmed: 15165670
Schizophr Res. 1995 Sep;17(1):5-13
pubmed: 8541250
Lancet. 2017 Sep 16;390(10100):1211-1259
pubmed: 28919117
Schizophr Res Cogn. 2016 Sep 28;6:9-14
pubmed: 28740819
J Cogn Neurosci. 2004 Nov;16(9):1669-79
pubmed: 15601527
Schizophr Bull. 2008 Jul;34(4):670-2
pubmed: 18495642
J Affect Disord. 2019 Feb 15;245:377-385
pubmed: 30423465
Schizophr Bull. 2011 Mar;37(2):300-5
pubmed: 20558531
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Psychiatry Clin Neurosci. 2014 Sep;68(9):701-11
pubmed: 24612235
Psychiatry Clin Neurosci. 2005 Oct;59(5):517-26
pubmed: 16194252
Soc Work Res Abstr. 1983 Fall;19(3):9-21
pubmed: 10264257
Psychiatry Res. 2014 Nov 30;219(3):426-30
pubmed: 25042425
Front Psychiatry. 2019 Nov 21;10:847
pubmed: 31824350
Psychiatry Clin Neurosci. 2007 Dec;61(6):602-9
pubmed: 18081619
Nat Rev Dis Primers. 2015 Nov 12;1:15067
pubmed: 27189524
Psychiatry Clin Neurosci. 2015 Dec;69(12):773-81
pubmed: 26129706
Sci Adv. 2019 Feb 06;5(2):eaau8317
pubmed: 30775438
Schizophr Bull. 2009 Jul;35(4):798-806
pubmed: 18308717
Mol Psychiatry. 2020 Nov;25(11):2905-2918
pubmed: 31391545
Am J Psychiatry. 2003 Oct;160(10):1768-74
pubmed: 14514489
J Pers Med. 2021 Apr 06;11(4):
pubmed: 33917377
J Psychiatr Res. 2017 Jun;89:48-54
pubmed: 28160626
Brain Behav Immun. 2020 Mar;85:186-191
pubmed: 30818031
Psychiatry Res. 1997 Nov 14;73(1-2):73-82
pubmed: 9463840
Asian J Psychiatr. 2020 Dec;54:102210
pubmed: 32599543
Schizophr Res Cogn. 2014 Oct 12;1(3):137-143
pubmed: 29379746
Schizophr Res Cogn. 2019 Feb 08;19:002-2
pubmed: 31832336
Schizophr Bull. 2014 Jul;40(4):813-23
pubmed: 23728248
Cogn Neuropsychiatry. 2007 Mar;12(2):128-43
pubmed: 17453895
Schizophr Res Cogn. 2019 Dec 10;20:100169
pubmed: 32154121
Schizophr Res. 2020 Apr 23;:
pubmed: 32336581

Auteurs

Ryotaro Kubota (R)

Department of Psychiatry, National Center of Neurology and Psychiatry Hospital, Tokyo 187-8551, Japan.

Ryo Okubo (R)

Department of Psychiatry, National Center of Neurology and Psychiatry Hospital, Tokyo 187-8551, Japan.
Department of Clinical Epidemiology, Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan.

Hisashi Akiyama (H)

Department of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan.

Hiroki Okano (H)

Department of Psychiatry, National Center of Neurology and Psychiatry Hospital, Tokyo 187-8551, Japan.

Satoru Ikezawa (S)

Endowed Institute for Empowering Gifted Minds, University of Tokyo Graduate School of Arts and Sciences, Tokyo 153-0041, Japan.

Akane Miyazaki (A)

Department of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan.

Atsuhito Toyomaki (A)

Department of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan.

Yohei Sasaki (Y)

Department of Clinical Epidemiology, Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan.

Yuji Yamada (Y)

Department of Psychiatry, National Center of Neurology and Psychiatry Hospital, Tokyo 187-8551, Japan.

Takashi Uchino (T)

Department of Neuropsychiatry, Toho University Faculty of Medicine, Tokyo 143-8541, Japan.

Takahiro Nemoto (T)

Department of Neuropsychiatry, Toho University Faculty of Medicine, Tokyo 143-8541, Japan.

Tomiki Sumiyoshi (T)

Department of Psychiatry, National Center of Neurology and Psychiatry Hospital, Tokyo 187-8551, Japan.
National Center of Neurology and Psychiatry, Department of Preventive Intervention for Psychiatric Disorders, National Institute of Mental Health, Tokyo 187-8553, Japan.

Naoki Yoshimura (N)

Department of Psychiatry, National Center of Neurology and Psychiatry Hospital, Tokyo 187-8551, Japan.

Naoki Hashimoto (N)

Department of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan.

Classifications MeSH